Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing (NCT03406208) | Clinical Trial Compass
CompletedNot Applicable
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
United States228 participantsStarted 2017-10-01
Plain-language summary
The aims of this study are to compare the effect and durability of two stress and symptom management programs tailored for patients with neurofibromatosis on quality of life and psychosocial functioning.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Has a diagnosis of NF1, NF2, or Schwannomatosis
* 18 years of age or older
* Is capable of completing and fully understanding the informed consent process, study procedures, and study assessments in English
* At least 6th grade self-reported reading level
* Self-reported difficulties coping with stress and NF-symptoms
* Score of 6 or higher on Perceived Stress Scale 4-Item (PSS-4)
Exclusion Criteria:
* Has major medical comorbidity not NF related expected to worsen in the next 12 months
* Recent (within past 3 months) change in antidepressant medication
* Recent (within past 3 months) participation in cognitive behavioral therapy or relaxation therapy
* Has significant mental health diagnosis requiring immediate treatment (e.g., bipolar disorder, psychotic disorder, active substance use dependence)
* Unable or unwilling to complete assessments electronically via REDCap
* Unable or unwilling to participate in group videoconferencing sessions